Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma
✍ Scribed by Luiz H.J. Pinto; Paulo C.V. Canary; Carlos M.M. Araújo; Silvia C. Bacelar; Luis Souhami
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 734 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background. A phase III randomized comparison of radiotherapy alone versus combination chemotherapy and concurrent continuous-course radiotherapy was performed at the Cleveland Clinic Foundation. Methods. Between March 1990 and June 1995, 100 patients with resectable stage III and IV squamous cell
Background. Treating the neck after organpreservation treatment with radiotherapy or chemoradiotherapy can be problematic. Methods. To develop management guidelines, we reviewed the results of a 100-patient phase-3 trial that had compared outcome after radiotherapy alone with outcome after chemorad
The current study presents mature results from a Phase III randomized trial comparing radiation therapy and concurrent chemoradiotherapy in patients with resectable American Joint Committee on Cancer Stage III and IV disease.
## Abstract ## BACKGROUND. Topical antifungal treatments are recommended but rarely used as first‐line therapy for oropharyngeal candidiasis (OPC) in patients with cancer. Miconazole Lauriad 50‐mg mucoadhesive buccal tablet (MBT) Loramyc reportedly delivered rapid and prolonged, effective concentr